Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Shares of Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the five analysts that are covering the firm, MarketBeat.com reports.

PORTLAND, IL, UNITED STATES, January 30, 2025 /EINPresswire / -- Increase in the number of spinal & joint <a target=_blank href= ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. 99.1% of AtriCure shares are owned by institutional investors. Comparatively ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

Check the time stamp on this data. Updated AI-Generated Signals for Orthofix Medical Inc. (OFIX) available here: OFIX. Type a ...

Corporate crises happen—and that means we have to plan for them. While it isn’t practical to prepare for every possible corporate crisis, there ...

GET MORE AI-GENERATED SIGNALS: January 16, 2025, 22:48 pm ET, BY Bill T.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...